Cargando…
Addendum: Liquid biopsy and multi-analyte testing guided treatment of HER2 positive periampullary adenocarcinoma with durable complete response after trastuzumab based therapy
| Autores principales: | , , , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Impact Journals LLC
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9629807/ https://www.ncbi.nlm.nih.gov/pubmed/36342460 http://dx.doi.org/10.18632/oncotarget.28296 |
| _version_ | 1784823470928953344 |
|---|---|
| author | Nagarkar, Rajnish Patil, Darshana Limaye, Sewanti Devhare, Pradip Ghaisas, Ashwini Srivastava, Navin Apurwa, Sachin Patil, Sanket John, Jinumary Raazi, Zarrine Shreenivas, Aditya Sambath, Janani Srinivasan, Ajay Kumar, Prashant Akolkar, Dadasaheb Datar, Rajan |
| author_facet | Nagarkar, Rajnish Patil, Darshana Limaye, Sewanti Devhare, Pradip Ghaisas, Ashwini Srivastava, Navin Apurwa, Sachin Patil, Sanket John, Jinumary Raazi, Zarrine Shreenivas, Aditya Sambath, Janani Srinivasan, Ajay Kumar, Prashant Akolkar, Dadasaheb Datar, Rajan |
| author_sort | Nagarkar, Rajnish |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9629807 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | Impact Journals LLC |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-96298072022-11-04 Addendum: Liquid biopsy and multi-analyte testing guided treatment of HER2 positive periampullary adenocarcinoma with durable complete response after trastuzumab based therapy Nagarkar, Rajnish Patil, Darshana Limaye, Sewanti Devhare, Pradip Ghaisas, Ashwini Srivastava, Navin Apurwa, Sachin Patil, Sanket John, Jinumary Raazi, Zarrine Shreenivas, Aditya Sambath, Janani Srinivasan, Ajay Kumar, Prashant Akolkar, Dadasaheb Datar, Rajan Oncotarget Addendum Impact Journals LLC 2022-11-02 /pmc/articles/PMC9629807/ /pubmed/36342460 http://dx.doi.org/10.18632/oncotarget.28296 Text en Copyright: © 2022 Nagarkar et al. https://creativecommons.org/licenses/by/3.0/This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/3.0/) (CC BY 3.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. |
| spellingShingle | Addendum Nagarkar, Rajnish Patil, Darshana Limaye, Sewanti Devhare, Pradip Ghaisas, Ashwini Srivastava, Navin Apurwa, Sachin Patil, Sanket John, Jinumary Raazi, Zarrine Shreenivas, Aditya Sambath, Janani Srinivasan, Ajay Kumar, Prashant Akolkar, Dadasaheb Datar, Rajan Addendum: Liquid biopsy and multi-analyte testing guided treatment of HER2 positive periampullary adenocarcinoma with durable complete response after trastuzumab based therapy |
| title | Addendum: Liquid biopsy and multi-analyte testing guided treatment of HER2 positive periampullary adenocarcinoma with durable complete response after trastuzumab based therapy |
| title_full | Addendum: Liquid biopsy and multi-analyte testing guided treatment of HER2 positive periampullary adenocarcinoma with durable complete response after trastuzumab based therapy |
| title_fullStr | Addendum: Liquid biopsy and multi-analyte testing guided treatment of HER2 positive periampullary adenocarcinoma with durable complete response after trastuzumab based therapy |
| title_full_unstemmed | Addendum: Liquid biopsy and multi-analyte testing guided treatment of HER2 positive periampullary adenocarcinoma with durable complete response after trastuzumab based therapy |
| title_short | Addendum: Liquid biopsy and multi-analyte testing guided treatment of HER2 positive periampullary adenocarcinoma with durable complete response after trastuzumab based therapy |
| title_sort | addendum: liquid biopsy and multi-analyte testing guided treatment of her2 positive periampullary adenocarcinoma with durable complete response after trastuzumab based therapy |
| topic | Addendum |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9629807/ https://www.ncbi.nlm.nih.gov/pubmed/36342460 http://dx.doi.org/10.18632/oncotarget.28296 |
| work_keys_str_mv | AT nagarkarrajnish addendumliquidbiopsyandmultianalytetestingguidedtreatmentofher2positiveperiampullaryadenocarcinomawithdurablecompleteresponseaftertrastuzumabbasedtherapy AT patildarshana addendumliquidbiopsyandmultianalytetestingguidedtreatmentofher2positiveperiampullaryadenocarcinomawithdurablecompleteresponseaftertrastuzumabbasedtherapy AT limayesewanti addendumliquidbiopsyandmultianalytetestingguidedtreatmentofher2positiveperiampullaryadenocarcinomawithdurablecompleteresponseaftertrastuzumabbasedtherapy AT devharepradip addendumliquidbiopsyandmultianalytetestingguidedtreatmentofher2positiveperiampullaryadenocarcinomawithdurablecompleteresponseaftertrastuzumabbasedtherapy AT ghaisasashwini addendumliquidbiopsyandmultianalytetestingguidedtreatmentofher2positiveperiampullaryadenocarcinomawithdurablecompleteresponseaftertrastuzumabbasedtherapy AT srivastavanavin addendumliquidbiopsyandmultianalytetestingguidedtreatmentofher2positiveperiampullaryadenocarcinomawithdurablecompleteresponseaftertrastuzumabbasedtherapy AT apurwasachin addendumliquidbiopsyandmultianalytetestingguidedtreatmentofher2positiveperiampullaryadenocarcinomawithdurablecompleteresponseaftertrastuzumabbasedtherapy AT patilsanket addendumliquidbiopsyandmultianalytetestingguidedtreatmentofher2positiveperiampullaryadenocarcinomawithdurablecompleteresponseaftertrastuzumabbasedtherapy AT johnjinumary addendumliquidbiopsyandmultianalytetestingguidedtreatmentofher2positiveperiampullaryadenocarcinomawithdurablecompleteresponseaftertrastuzumabbasedtherapy AT raazizarrine addendumliquidbiopsyandmultianalytetestingguidedtreatmentofher2positiveperiampullaryadenocarcinomawithdurablecompleteresponseaftertrastuzumabbasedtherapy AT shreenivasaditya addendumliquidbiopsyandmultianalytetestingguidedtreatmentofher2positiveperiampullaryadenocarcinomawithdurablecompleteresponseaftertrastuzumabbasedtherapy AT sambathjanani addendumliquidbiopsyandmultianalytetestingguidedtreatmentofher2positiveperiampullaryadenocarcinomawithdurablecompleteresponseaftertrastuzumabbasedtherapy AT srinivasanajay addendumliquidbiopsyandmultianalytetestingguidedtreatmentofher2positiveperiampullaryadenocarcinomawithdurablecompleteresponseaftertrastuzumabbasedtherapy AT kumarprashant addendumliquidbiopsyandmultianalytetestingguidedtreatmentofher2positiveperiampullaryadenocarcinomawithdurablecompleteresponseaftertrastuzumabbasedtherapy AT akolkardadasaheb addendumliquidbiopsyandmultianalytetestingguidedtreatmentofher2positiveperiampullaryadenocarcinomawithdurablecompleteresponseaftertrastuzumabbasedtherapy AT datarrajan addendumliquidbiopsyandmultianalytetestingguidedtreatmentofher2positiveperiampullaryadenocarcinomawithdurablecompleteresponseaftertrastuzumabbasedtherapy |